Lipocine - Rasio total nilai perusahaan marang pendapatan LPCN

lipocine.com (LPCN) - logo korporat

The enterprise value-to-revenue ratio illustrates the asset's valuation trend, where -1296.79 serves as the current metric level. The success of Lipocine Inc. (LPCN) relies on its oral drug delivery system coupled with strict control over R&D expenditures. This non-cyclical biotech remains resilient to macroeconomic shifts, as demand for the treatment of endocrine pathologies is independent of GDP. Growth is driven by liver drug trials and new patents.

LPCN Lipocine Inc.: Rasio nilai perusahaan marang pendapatan ing interval 23.11.2025 - 20.11.2026

Lipocine Corporation - rincian analitis lan metrik utama (LPCN)

- rega saham lan prakiraan rega para ahli:
Analisis wiwitan perusahaan:lipocine.com
Barang unggulan Lipocine Corp

The stable management of Lipocine Inc. (LPCN), with its successful track record in developing drug delivery systems, provides the foundation for valuing the business via EV/Sales, which measures the company's value excluding debt relative to revenue. By analyzing historical EV/Sales levels on the GURU.Markets platform, an investor can discern real market expectations for the company's earnings, stripped of the influence of capital structure and interest rates.

Analisis pesaing

ASND: Rasio nilai perusahaan marang pendapatan|MDGL: Multiplikator EV/Sales|CORT - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Rhythm Corp|Akero Corp (AKRO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan metsera.com (MTSR)|Nilai perusahaan marang pendapatan moonlaketx.com MLTX|Multiplikator EV/Sales CRNX (Crinetics Pharmaceuticals, Inc.)|NAMS: Rasio nilai perusahaan marang pendapatan|SLNO - Rasio nilai perusahaan marang pendapatan|Amicus Pharma (FOLD) - Nilai perusahaan marang pendapatan|ETNB: Multiplikator EV/Sales|AGIO - Rasio total nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan GPCR|Multiplikator nilai perusahaan marang pendapatan MiMedx MDXG|Rasio nilai perusahaan marang pendapatan Rezolute Corp (RZLT)|Nilai perusahaan marang pendapatan Lexicon Corp LXRX|Rasio nilai perusahaan marang pendapatan MBX Biosciences, Inc. MBX|Multiplikator EV/Sales altimmune.com ALT|AARD - Rasio nilai perusahaan marang pendapatan|Sagimet - Koefisien nilai perusahaan marang pendapatan|BioAge Labs Inc. (BIOA) - Rasio nilai perusahaan marang pendapatan|Nilai perusahaan marang volume dodolan BMEA (Biomea Fusion, Inc.)|QNCX (quincetx.com) - Multiplikator EV/Sales|GUTS: Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan vtvtherapeutics.com (VTVT)|ATPC (Agape ATP) - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Pluristem Therapeutics PLUR|SYBX: Rasio nilai perusahaan marang pendapatan|MTNB - Rasio nilai perusahaan marang pendapatan|Spruce Biosciences, Inc. (SPRB) - Nilai perusahaan marang pendapatan|GLTO: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Carmell Corp. (CTCX)|LUMO (Lumos Therapeutics) - Multiplikator EV/Sales|Organovo Corp (ONVO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Radius Recycling (RDUS)